View |
|
DRP-1006
|
Co-Amoxiclav
|
Enhancin
|
1g
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Sun Pharmaceutical Industries Ltd., India
|
India
|
Automatic Renewal
|
20 March 2023
|
12 August 2028
|
View |
|
DRP-1006-03
|
Co-Amoxiclav
|
Prevaclav 1g
|
1 g
|
Film-Coated Tablet
|
Antibacterial (Penicillin)
|
Sun Pharmaceutical Industries Limited
|
India
|
Renewal
|
09 July 2023
|
12 August 2028
|
View |
|
DRP-1006-04
|
Co-Amoxiclav
|
None
|
1 g
|
Film-Coated Tablet
|
Prescription Drug (Rx)
|
Sun Pharmaceuticals Industries LImited
|
India
|
CLIDP Conversion
|
10 April 2024
|
12 August 2028
|
View |
|
DRP-10060
|
Each kit contains:
Wintergreen Oil + Camphor + Turpentine Oil + Eucalyptus Oil + Menthol + Clove Oil + Cinnamon Oil [Relispray Plus] Lidocaine + Cetrimide [Mistdress] Povidone-Iodine [Vinodine]
|
Fast Aid
|
200 mg/100 mg/100 mg/60 mg/40 mg/10 mg/5 mg per g
(20%/10%/10%/6%/4%/1%/0.5% w/w) + 10 mg/1 mg per g (1%/0.1% w/w) + 50 mg/g (5% w/w)
|
Topical Aerosol Spray Solution
|
Counterirritant/Local Anesthetic/Antiseptic
|
Midas-Care Pharmaceuticals Pvt. Ltd.
|
India
|
-
|
13 January 2022
|
18 April 2027
|
View |
|
DRP-10061-01
|
Ketorolac Trometamol
|
Ketralax
|
30 mg/mL
|
Solution for Injection (IM/IV)
|
Non-Opioid Analgesic
|
Aju Pharm Co., Ltd
|
Korea
|
Renewal
|
26 October 2023
|
18 September 2028
|
View |
|
DRP-10061-03
|
Ketorolac trometamol
|
Ketonob
|
30 mg/mL
|
Solution for Injection (IM/IV)
|
Non-Opioid Analgesic
|
Aju Pharm Co., Ltd.
|
Korea
|
CLIDP Conversion
|
26 October 2023
|
18 September 2028
|
View |
DRP-10062_PI_01.pdf
|
DRP-10062
|
Bicalutamide
|
Casodex
|
50 mg
|
Tablet
|
Anti-androgen
|
Corden Pharma GmbH
|
Germany
|
Renewal
|
22 November 2023
|
02 April 2029
|
View |
|
DRP-10063
|
Doxofylline
|
Doxof
|
400 mg
|
Tablet
|
Drugs for Obstructive Airway Discases (Xanthine)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
18 October 2023
|
21 February 2029
|
View |
|
DRP-10064
|
Candesartan Cilexetil
|
Candez
|
8 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
08 January 2024
|
11 May 2029
|
View |
|
DRP-10065
|
Candesartan Cilexetil
|
Candez
|
16 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
14 March 2024
|
11 May 2029
|
View |
|
DRP-10066
|
Prednisolone Acetate
|
Lumepred
|
10 mg/mL (1.0 % w/v)
|
Ophthalmic Suspension (Eye Drops)
|
Corticosteroid
|
Axa Parenterals Limited
|
India
|
Initial (Reconstruction)
|
12 August 2024
|
26 July 2026
|
View |
|
DRP-10067
|
Losartan Potassium
|
Prolostan
|
100 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Chempro Pharma Private Limited
|
India
|
Automatic Renewal [Revalidation (Variation: PCPR Conversion)
|
25 October 2022
|
26 May 2028
|
View |
|
DRP-10068
|
Cefpodoxime (As Proxetil)
|
Kefpoxime
|
100 mg/5 mL
|
Powder for suspension
|
Antibacterial(Cephalosporin)
|
Scott-Edil Advance Research Laboratories &
Education Limited Hill
|
India
|
PCPR
|
16 July 2021
|
04 December 2025
|
View |
|
DRP-10068-01
|
Cefpodoxime (As Proxetil)
|
None
|
100 mg/5 ml
|
Powder for Suspension
|
-
|
Scott-Edil Advance Research Laboratories &
Education Limited
|
India
|
-
|
11 November 2021
|
04 December 2025
|
View |
|
DRP-10068-02
|
Cefpodoxime (as proxetil)
|
Swich
|
100 mg/ 5mL
|
powder for suspension
|
Antibacterial (Cephalosporin)
|
Scott Edil Advance research Laboratories & education Limited
|
India
|
-
|
16 February 2022
|
04 December 2025
|
View |
|
DRP-10069
|
Cefpodoxime (As Proxetil)
|
Kefpoxime
|
200 mg
|
Film-Coated Tablet
|
-
|
Scott-Edil Advance Research Laboratories &
Education Limited Hill
|
India
|
-
|
16 July 2021
|
28 October 2025
|
View |
|
DRP-10069-01
|
Cefpodoxime (As Proxetil)
|
None
|
200mg
|
Film-Coated Tablet
|
-
|
Scott-Edil Advance Research Laboratories &
Education Limited
|
India
|
-
|
26 October 2021
|
28 October 2025
|
View |
|
DRP-10069-02
|
Cefpodoxime(As Proxetil)
|
Swich
|
200mg
|
Film-Coated Tablet
|
Antibacterial(Cephalosporin)
|
Scott-Edil Advance Research Laboratories & Education Limited
|
India
|
CLIDP
|
21 January 2022
|
28 October 2025
|
View |
|
DRP-10070
|
CEFALEXIN (as monohydrate)
|
ISEF
|
125 mg/ 5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Scott-Edil Advance Research Laboratories &
Education Limited Hill
|
India
|
Renewal
|
21 April 2024
|
10 October 2029
|
View |
|
DRP-10070-01
|
Cefalexin (As Monohydrate)
|
None
|
125mg/5mL
|
Powder for oral suspension
|
-
|
Scott-Edil Advance Research Laboratories &
Education Limited
|
India
|
-
|
26 October 2021
|
10 October 2024
|